Eyesiu's partnering strategy at this stage is to build value with its internal products by finding partners that support its development: either geographically as co-development partnerships or indication-specific by veterinary use or specific formulation. As products move through development towards their intended markets, commercial partnering at (co-)development or marketed stage will become part of our strategy if capital needs require such a partner. 

Its platform has provided innovative ophthalmology, dermatology, neurology and pulmonology products. Each of these products has different traits to a pharma/biotech company in need of a novel product in the large and growing therapeutics market.